ArticleCancer biology & therapy2019

LncRNA TATDN1 contributes to the cisplatin resistance of non-small cell lung cancer through TATDN1/miR-451/TRIM66 axis.

Linmei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.